Recruiting NA Asthma Intermittent, Uncontrolled

New treatment option for Asthma Intermittent, Uncontrolled

Official title Εffectiveness of a Digital Social Intervention in Primary Care

ClinicalTrials.gov ID: NCT06849245

What this study is testing

What it's testing
The goal of this study is to deliver a definitive randomised controlled trial to measure the effectiveness and assess cost-effectiveness of a digital social intervention for patients with asthma, composed of promoting engagement with online peer support in a primary care consultation, followed by engagement with online peer support for 12 months. The main questions/objectives this study aims to answer/address are: Does promoting engagement with an online health community in primary care help people with troublesome asthma to experience fewer asthma symptoms?
  • Time commitment: about 3 months
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 99

You may be able to join if

  • To participate in the study, participants will need to:
  • Be adult asthma patients (aged 18 to 99) who have expressed their interest in digital social interventions in the recruitment survey.
  • Report troublesome asthma (i.e. an ACT score of less than 20) in the recruitment survey).
  • Be competent to consent for themselves, as determined by the healthcare professional delivering the consultation. There are no specific criteria for...

You likely can't join if

  • Patients who are already members of the Asthma + Lung UK online health community or other asthma online health communities/Facebook groups (i.e...
  • Palliative or end of life patients.
  • Patients receiving institutional long-term care (receiving total care in residential homes or living in nursing homes).
  • Patients considered unsuitable to take part in the study by their general practitioners/nurses. There are no specific criteria for selecting...

The study team makes the final eligibility decision.

Where it's taking place

  • Exeter, United Kingdom
  • Leicester, United Kingdom
  • London, United Kingdom
  • Newcastle upon Tyne, United Kingdom
  • Norwich, United Kingdom

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 3 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Exeter, United Kingdom; Leicester, United Kingdom; London, United Kingdom; Newcastle upon Tyne, United Kingdom; Norwich, United Kingdom. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.